Alvelestat (MPH996) for the Treatment of ALpha-1 ANTitrypsin Deficiency

Conditions:   Alpha-1 Antitrypsin Deficiency (AATD);   Pi*ZZ, Pi*SZ, or Pi*Null Phenotype;   Emphysema or COPD Interventions:   Drug: Alvelestat (MPH996);   Other: Placebo Sponsors:   University of Alabama at Birmingham;   National Institutes of Health (NIH);   Mereo BioPharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials